Wells Fargo & Company Coll Plant Biotechnologies LTD Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Wells Fargo & Company holds 4,000 shares of CLGN stock, worth $14,720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000Holding current value
$14,720% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CLGN
# of Institutions
16Shares Held
2.01MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC485KShares$1.78 Million0.21% of portfolio
-
Pinnacle Associates LTD468KShares$1.72 Million0.04% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.71 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$1.02 Million2.69% of portfolio
-
Brown Advisory Inc119KShares$439,6310.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $40.8M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...